Applications of microarrays in the pharmaceutical industry

Current Opinion in Pharmacology

Volumn 2, Issue 5, 2002, Pages 551-554

  Crowther, Daniel J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENTARY DNA; DYCLONINE;

ARTICLE; CAENORHABDITIS ELEGANS; CANCER; CANCER CLASSIFICATION; CONTROLLED STUDY; DATA BASE; DNA MICROARRAY; DROSOPHILA MELANOGASTER; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG MECHANISM; DRUG RESEARCH; DRUG TOXICITY; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENETIC TOXICOLOGY; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0036792495     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00207-2     Document Type: Review

References (36)

1. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971.
2. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 1995, 270:484-487.
3. Hubank M, Schatz DG: cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. Methods Enzymol 1999, 303:325-349.
4. Blohm DH, Guiseppi-Elie A: New developments in microarray technology. Curr Opin Biotechnol 2001, 12:41-47.
5. Hughes TR, Shoemaker DD: DNA microarrays for expression profiling. Curr Opin Chem Biol 2001, 5:21-25.
6. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
7. Hill AA, Hunter CP, Tsung BT, Tucker-Kellogg G, Brown EL: Genomic analysis of gene expression in C. elegans. Science 2000, 290:809-812.
8. Spellman PT, Rubin GM: Evidence for large domains of similarly expressed genes in the Drosophila genome. J Biol 2002, 1:5.
9. Shoemaker DD, Schadt EE, Armour CD, He YD, Garrett-Engele P, McDonagh PD, Loerch PM, Leonardson A, Lum PY, Cavet G et al.: Experimental annotation of the human genome using microarray technology. Nature 2001, 409:922-927.
10. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A et al.: Large scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002, 99:4465-4470.
11. Clark EA, Golub TR, Lander ES, Hymes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406:532-535.
12. Diehn M, Eisen MB, Botstein D, Brown PO: Large scale identification of secreted and membrane-associated gene products using DNA microarrays. Nat Genet 2000, 25:58-62.
13. Eisen EB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868.
14. Kim SK, Lund J, Kiraly M, Duke K, Jiang M, Stuart JM, Eizinger A, Wylie BN, Davidson GS: A gene expression map for Caenorhabditis elegans. Science 2001, 293:2087-2092.
15. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235.
16. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Hongyue D, He YD et al.: Functional discovery via a compendium of expression profiles. Cell 2000, 102:109-125.
17. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT et al.: A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000, 24:236-244.
18. Ulrich R, Friend SH: Toxicogenomics and drug discovery: will new techniques help us to produce better drugs? Nat Rev Drug Discov 2002, 1:84-88.
19. Fielden MR, Zacharewski TR: Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol Sci 2001, 60:6-10.
20. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG: Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001, 120:359-368.
21. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, Glover E, Silander T, Craven MW, Reddy JK et al.: Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 2001, 60:1189-1194.
22. Waring JF, Jolly RA, Ciurlionis R, Lum PY, Praestgarrd JT, Morfitt DC, Buratto B, Roberts C, Schadt E, Ulrich RG: Clustering of hepatotoxins based on mechanisms of toxicity using gene expression profiles. Toxicol Appl Pharmacol 2001, 175:23-42.
23. Mirnics K, Middleton, Marquez, Lewis DA, Levitt P: Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefontal cortex. Neuron 2000, 28:53-67.
24. Diehn M, Relman AR: Comparing functional genomic datasets: lessons from DNA microarray analyses of host pathogen interactions. Curr Opin Microbiol 2001, 4:95-101.
25. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA et al.: Molecular classification of cancer; class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
26. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffery SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA et al.: Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
27. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A et al.: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406:536-540.
28. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
29. Van't Veer LJ, Dai H, van de Vijer MJ, He YD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
30. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP et al.: Gene expression correlates of clinical prostate cancer behaviour. Cancer Cell 2002, 1:203-209.
31. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C et al.: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436-442.
32. Yeoh EJ, Ross ME, Shertleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A et al.: Classification, subtype discovery and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143.
33. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RCT, Gaasenbeek M, Angelo M, Reich M, Pinkus GS et al.: Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nat Med 2002, 8:68-73.
34. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukaemia. Nat Genet 2002, 30:41-47.
35. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC et al.: Minimum information about a microarray experiment (MIAME) - towards standards for microarray data. Nat Genet 2001, 29:365-371.
36. Bramza A, Robinson A, Cameron G, Ashburner MJ: One stop shop for microarray data. Nature 2000, 403:699-700.